TCTR20191104001CompletedPhase 4
Immunogenicity of inactivated vero cell culture-derived Japanese encephalitis vaccine in children and adolescents after hematopoietic stem cell transplantation
Faculty of Medicine Ramathibodi Hospital, Mahidol University0 sites37 target enrollmentStarted: November 4, 2019Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Enrollment
- 37
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 0 N/A (No limit) to 25 Years (—)
- Sex
- All
Inclusion Criteria
- •Patients who had finished their hematopoietic stem cell transplantation for more than 1 year
Exclusion Criteria
- •No immunosuppressive therapy at least 6 months before enrollment
- •No evidence of acute or chronic graft versus host disease at the time of enrollment
Investigators
Similar Trials
Completed
Not Applicable
Safety and effectiveness of boosting healthy adults with new cell-culture-derived JE vaccine (JESPECT), where mouse-brain-derived vaccine (JEVAX) has previously been administered.Japanese encephalitisPublic Health - Other public healthInfection - Other infectious diseasesInflammatory and Immune System - Normal development and function of the immune systemACTRN12611001090909Csongor Oltvolgyi150
Active, not recruiting
Not Applicable
Immunogenicity of the Investigational Inactivated, Split-Virion Influenza Vaccine Administered by the Intradermal Route in Comparison with the Intramuscular Reference Vaccine Vaxigrip in the Elderly - NDVaccination of elderly subjects aged 60 years and over with inactivated, split-virion inf luenza vaccine administered by the intradermal route using Vaxigrip as IM reference vaccineMedDRA version: 6.1Level: SOCClassification code 10021881EUCTR2006-002366-18-ITSANOFI PASTEUR3,655
Active, not recruiting
Not Applicable
Immunogenicity of the Investigational Inactivated, Split-Virion Influenza Vaccine Administered by the Intradermal Route in Comparison with the Intramuscular Reference Vaccine Vaxigrip® in the Elderly.Vaccination of elderly subjects aged 60 years and over with inactivated, split-virion influenza vaccine administered by the intradermal route using Vaxigrip® as IM reference vaccine.EUCTR2006-002366-18-LTSanofi Pasteur SA3,655
Active, not recruiting
Not Applicable
Immunogenicity of the Investigational Inactivated, Split-Virion Influenza Vaccine Administered by the Intradermal Route in Comparison with the Intramuscular Reference Vaccine Vaxigrip® in the Elderly.EUCTR2006-002366-18-BESanofi Pasteur SA3,655
Active, not recruiting
Phase 1
Study for the research of predictive factors of response to Tofacitinib therapy in patients with ulcerative rectal colitis.lcerative colitisMedDRA version: 20.0Level: LLTClassification code 10045282Term: UCSystem Organ Class: 100000004856EUCTR2018-004890-28-ITDIP. MEDICINA DEI SISTEMI UNIVERSITà DEGLI STUDI DI ROMA TOR VERGATA60